LRP8 and neoplasm: LRP8 was also identified in a computational study searching for transmembrane genes more strongly expressed in TNBCs than in various normal tissues for the development of an ADC approach.35 Antibodies targeting LRP8 (LRP8‐binding protein) have recently been patented by AbbVie, but their effects on cell survival or tumor growth have yet to be reported.